Accuracy of fine-needle aspiration cytology of head and neck masses.


Journal

Diagnostic cytopathology
ISSN: 1097-0339
Titre abrégé: Diagn Cytopathol
Pays: United States
ID NLM: 8506895

Informations de publication

Date de publication:
May 2019
Historique:
received: 28 08 2018
revised: 21 10 2018
accepted: 24 10 2018
pubmed: 30 11 2018
medline: 17 7 2019
entrez: 30 11 2018
Statut: ppublish

Résumé

Head and neck masses are a common presentation in daily practice and can be challenging to both clinicians and cytopathologists. Fine needle aspiration cytology (FNAC) is a widely used method for the diagnosis of head and neck masses. The aim of the study was to assess our institutional experience of the accuracy of FNAC in the diagnosis of head and neck masses. A total of 1262 FNACs were conducted from January 2013 to December 2016 and subdivided into benign and malignant categories. The thyroid and salivary glands FNACs were classified according to the Bethesda System for Reporting Thyroid cytopathology and to the Milan System for Reporting Salivary Gland Cytopathology respectively. The measures of diagnostic accuracy of FNAC were determined taking histology as a gold standard. A total of 7 false negative (FN) and 6 false positive (FP) FNACs were identified. Overall sensitivity and specificity of FNAC for a malignant diagnosis were 92% and 94.4%, respectively. Accuracy of FNACs of head and neck masses was 93.5% for all sites. The salivary gland group had the highest rate of FN (2.8%). All FP were reported in the thyroid group. These cases were cytologically classified suspicious for malignancy (n = 3) and papillary carcinoma (n = 3) and proved to be lymphocytic thyroiditis on final histology. Among the most common locations, cytology of lymph nodes provided the best sensitivity (98.2%). Salivary glands as well as lymph nodes had the best specificity (100%). FNAC of head and neck masses has a high accuracy allowing a correct therapeutic management. However, this accuracy depends on the anatomic location of the mass.

Sections du résumé

BACKGROUND BACKGROUND
Head and neck masses are a common presentation in daily practice and can be challenging to both clinicians and cytopathologists. Fine needle aspiration cytology (FNAC) is a widely used method for the diagnosis of head and neck masses. The aim of the study was to assess our institutional experience of the accuracy of FNAC in the diagnosis of head and neck masses.
METHODS METHODS
A total of 1262 FNACs were conducted from January 2013 to December 2016 and subdivided into benign and malignant categories. The thyroid and salivary glands FNACs were classified according to the Bethesda System for Reporting Thyroid cytopathology and to the Milan System for Reporting Salivary Gland Cytopathology respectively. The measures of diagnostic accuracy of FNAC were determined taking histology as a gold standard.
RESULTS RESULTS
A total of 7 false negative (FN) and 6 false positive (FP) FNACs were identified. Overall sensitivity and specificity of FNAC for a malignant diagnosis were 92% and 94.4%, respectively. Accuracy of FNACs of head and neck masses was 93.5% for all sites. The salivary gland group had the highest rate of FN (2.8%). All FP were reported in the thyroid group. These cases were cytologically classified suspicious for malignancy (n = 3) and papillary carcinoma (n = 3) and proved to be lymphocytic thyroiditis on final histology. Among the most common locations, cytology of lymph nodes provided the best sensitivity (98.2%). Salivary glands as well as lymph nodes had the best specificity (100%).
CONCLUSION CONCLUSIONS
FNAC of head and neck masses has a high accuracy allowing a correct therapeutic management. However, this accuracy depends on the anatomic location of the mass.

Identifiants

pubmed: 30488579
doi: 10.1002/dc.24120
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

394-399

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Soumaya Rammeh (S)

Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.
Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.

Emna Romdhane (E)

Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.
Faculté des Sciences de Tunis, Université de Tunis El Manar, Tunis, Tunisie.

Asma Sassi (A)

Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.
Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.

Linda Belhajkacem (L)

Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.
Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.

Ahlem Blel (A)

Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.
Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.

Meriem Ksentini (M)

Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.
Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.

Rim Lahiani (R)

Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.
Department of Otorhinolaryngology, Charles Nicolle Hospital, Tunis, Tunisia.

Faten Farah (F)

Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.
Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.

Mamia Ben Salah (MB)

Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.
Department of Otorhinolaryngology, Charles Nicolle Hospital, Tunis, Tunisia.

Mohamed Ferjaoui (M)

Faculté de Médecine de Tunis, Université de Tunis El Manar, UR17ES15, Tunis, Tunisie.
Department of Otorhinolaryngology, Charles Nicolle Hospital, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH